HTG Molecular Diagnostics, Inc. (HTGM): Price and Financial Metrics
GET POWR RATINGS... FREE!
HTGM POWR Grades
- Sentiment is the dimension where HTGM ranks best; there it ranks ahead of 81.06% of US stocks.
- HTGM's strongest trending metric is Stability; it's been moving up over the last 173 days.
- HTGM's current lowest rank is in the Stability metric (where it is better than 12.45% of US stocks).
HTGM Stock Summary
- With a market capitalization of $38,639,968, Htg Molecular Diagnostics Inc has a greater market value than only 6.54% of US stocks.
- Revenue growth over the past 12 months for Htg Molecular Diagnostics Inc comes in at -57.43%, a number that bests merely 5.45% of the US stocks we're tracking.
- In terms of volatility of its share price, HTGM is more volatile than 92.44% of stocks we're observing.
- Stocks that are quantitatively similar to HTGM, based on their financial statements, market capitalization, and price volatility, are AKBA, SREV, NAOV, XGN, and AVGR.
- HTGM's SEC filings can be seen here. And to visit Htg Molecular Diagnostics Inc's official web site, go to www.htgmolecular.com.
HTGM Valuation Summary
- HTGM's price/sales ratio is 4.3; this is 63.71% lower than that of the median Healthcare stock.
- HTGM's price/earnings ratio has moved up 3.6 over the prior 76 months.
- Over the past 76 months, HTGM's price/sales ratio has gone down 23.5.
Below are key valuation metrics over time for HTGM.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| HTGM | 2019-09-10 | 1.1 | 2.1 | -1.4 | -1.3 |
| HTGM | 2018-07-02 | 5.5 | 3.1 | -5.2 | -4.9 |
| HTGM | 2018-06-04 | 6.7 | 3.8 | -6.3 | -6.1 |
| HTGM | 2018-03-08 | 7.9 | -14.6 | -2.9 | -3.0 |
| HTGM | 2016-10-24 | 3.4 | 4.3 | -0.7 | -1.0 |
| HTGM | 2016-04-26 | 6.0 | 0.9 | -1.1 | -2.1 |
HTGM Price Target
For more insight on analysts targets of HTGM, see our HTGM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $12.75 | Average Broker Recommendation | 1.5 (Moderate Buy) |
HTGM Stock Price Chart Interactive Chart >
HTGM Price/Volume Stats
| Current price | $6.01 | 52-week high | $11.25 |
| Prev. close | $6.16 | 52-week low | $3.50 |
| Day low | $5.74 | Volume | 65,900 |
| Day high | $6.24 | Avg. volume | 126,458 |
| 50-day MA | $4.96 | Dividend yield | N/A |
| 200-day MA | $5.26 | Market Cap | 43.67M |
HTG Molecular Diagnostics, Inc. (HTGM) Company Bio
HTG Molecular Diagnostics, Inc. develops and markets technology platforms that facilitate the routine use of complex molecular profiling. The companys HTG Edge and HTG EdgeSeq platforms consist of instrumentation, consumables, and software analytics that are used in molecular profiling applications, including tumor profiling, biomarker development and prospectively, and molecular diagnostic testing. The company was founded in 1997 and is based in Tucson, Arizona.
Latest HTGM News From Around the Web
Below are the latest news stories about Htg Molecular Diagnostics Inc that investors may wish to consider to help them evaluate HTGM as an investment opportunity.
HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)TUCSON, Ariz., July 23, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that, on July 13th and July 22nd, 2021 the Compensation Committee of the HTG Board of Directors granted inducement stock option awards to purchase an aggregate of 30,000 shares of common stock to two employees who have recently joined HTG. These stock option awards have exercise prices of $5.85 and $5.42 per |
HTG Forms New Drug Discovery Business UnitNew unit to focus on development of drug candidates through use of HTG Transcriptome PanelTUCSON, Ariz., July 20, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the creation of a new business unit, HTG Therapeutics. HTG plans to use this new drug discovery business unit to leverage its capabilities and expand upon the utility of the HTG EdgeSeq platform technology in the develop |
Is HTG Molecular Diagnostics (NASDAQ:HTGM) Using Debt In A Risky Way?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously... |
HTG Receives First Commercial Orders for its Planned HTG Transcriptome Panel and Announces the Signing of Two European Early Adopter Program AgreementsTUCSON, Ariz., June 22, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has received the first commercial orders for its planned HTG Transcriptome Panel and has signed agreements with its first two Early Adopter Program (EAP) collaborators in Europe. HTG has now signed EAP agreements with customers in both the US and Europe and continues to progress toward its planned third qu |
Here is What Hedge Funds Think About HTG Molecular Diagnostics, Inc. (HTGM)Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors’ consensus returns have been exceptional. In the following paragraphs, we find out […] |
HTGM Price Returns
| 1-mo | 3.44% |
| 3-mo | 35.06% |
| 6-mo | -6.97% |
| 1-year | -43.96% |
| 3-year | -86.28% |
| 5-year | -83.51% |
| YTD | 25.47% |
| 2020 | -54.50% |
| 2019 | -72.37% |
| 2018 | 25.12% |
| 2017 | -9.38% |
| 2016 | -48.62% |
Continue Researching HTGM
Here are a few links from around the web to help you further your research on Htg Molecular Diagnostics Inc's stock as an investment opportunity:Htg Molecular Diagnostics Inc (HTGM) Stock Price | Nasdaq
Htg Molecular Diagnostics Inc (HTGM) Stock Quote, History and News - Yahoo Finance
Htg Molecular Diagnostics Inc (HTGM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...